Your session is about to expire
← Back to Search
Aftercare Treatment for Obsessive-Compulsive Disorder
N/A
Waitlist Available
Led By Carolyn Rodriguez, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Children younger than 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is for OCD patients who have completed a different study protocol and are now looking for aftercare treatment options.
Who is the study for?
This trial is for adults with Obsessive Compulsive Disorder (OCD) who have finished a previous study at the Rodriguez Lab. They must understand the risks and benefits of this study, be able to consent, and speak English. It's not open to anyone under 18 or those currently having thoughts of suicide.
What is being tested?
The trial offers ongoing treatment options for OCD through pharmacotherapy (medication) and psychotherapy (counseling). It's designed for patients from prior studies at the Rodriguez Lab to continue receiving care and support.
What are the potential side effects?
While specific side effects are not listed here, generally, medications can include nausea, headache, sleep disturbances or mood changes; psychotherapy might bring up uncomfortable emotions but is usually safe.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 14 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: PharmacotherapyActive Control1 Intervention
Participants will receive pharmacotherapy by a psychiatrist
Group II: PsychotherapyActive Control1 Intervention
Participants will receive evidenced based psychotherapy by a trained psychologist
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,467 Previous Clinical Trials
17,495,902 Total Patients Enrolled
16 Trials studying Obsessive-Compulsive Disorder
1,210 Patients Enrolled for Obsessive-Compulsive Disorder
Carolyn Rodriguez, MD, PhDPrincipal Investigator - Assistant Professor, Stanford University
Stanford University
6 Previous Clinical Trials
113 Total Patients Enrolled
4 Trials studying Obsessive-Compulsive Disorder
104 Patients Enrolled for Obsessive-Compulsive Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I understand the risks, benefits, and procedures of the study and can consent.I am under 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Pharmacotherapy
- Group 2: Psychotherapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger